US FDA Wants Opioid Prescribing Guidelines To Be Highly Specific, But It May Have To Compromise
Executive Summary
National Academies of Sciences, Engineering, and Medicine committee meeting suggest it is difficult to write condition-specific guidelines for opioid prescribing in the primary care setting.
You may also be interested in...
FDA Review Modernization Fully Funded
After receiving $25.1m in FY 2019, Congress gave another $1.9m in FY 2020, which appropriators said combined reaches the $27m requested for the FY 2020 budget.
Opioid Prescribing Guidelines From US FDA Could Be A While After NASEM Report
National Academies report identifies gaps in the existing data – including on the question of whether developing prescribing guidelines would even have an impact on the opioid epidemic.
Stability Key For US FDA, But Changes Needed For Consumer Health Are Clear
Some stakeholders in regulated industries are concerned that without a history as a public agency executive, Stephen Hahn could have an unpredictable tenure as FDA commissioner. Still, consumer health industry trade groups note regulatory topics crucial to the industry's growth and consumer safety should be clear.